BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29564772)

  • 21. Genome Editing of Silkworms.
    Tsubota T; Sezutsu H
    Methods Mol Biol; 2017; 1630():205-218. PubMed ID: 28643261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental competence of porcine genome-edited zygotes.
    Gil MA; Martinez CA; Nohalez A; Parrilla I; Roca J; Wu J; Ross PJ; Cuello C; Izpisua JC; Martinez EA
    Mol Reprod Dev; 2017 Sep; 84(9):814-821. PubMed ID: 28471514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome editing comes of age.
    Kim JS
    Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
    Ben Jehuda R; Shemer Y; Binah O
    Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the impact of chromatin conformation on genome editing tools.
    Chen X; Rinsma M; Janssen JM; Liu J; Maggio I; Gonçalves MA
    Nucleic Acids Res; 2016 Jul; 44(13):6482-92. PubMed ID: 27280977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
    Kawahara A; Hisano Y; Ota S; Taimatsu K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering.
    Singh A; Chakraborty D; Maiti S
    Chem Soc Rev; 2016 Dec; 45(24):6666-6684. PubMed ID: 27711765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A guide for drug inducible genome editing with HIT systems.
    Zhao C; Wei S; Wang Y
    Methods Enzymol; 2019; 621():53-68. PubMed ID: 31128789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.
    Zhang HX; Zhang Y; Yin H
    Mol Ther; 2019 Apr; 27(4):735-746. PubMed ID: 30803822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome Editing of Pig.
    Watanabe M; Nagashima H
    Methods Mol Biol; 2017; 1630():121-139. PubMed ID: 28643255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide specificity of plant genome editing by both CRISPR-Cas9 and TALEN.
    Bessoltane N; Charlot F; Guyon-Debast A; Charif D; Mara K; Collonnier C; Perroud PF; Tepfer M; Nogué F
    Sci Rep; 2022 Jun; 12(1):9330. PubMed ID: 35665758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rabbit models for biomedical research revisited via genome editing approaches.
    Honda A; Ogura A
    J Reprod Dev; 2017 Oct; 63(5):435-438. PubMed ID: 28579598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
    Farooq R; Hussain K; Nazir S; Javed MR; Masood N
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases.
    Renaud JB; Boix C; Charpentier M; De Cian A; Cochennec J; Duvernois-Berthet E; Perrouault L; Tesson L; Edouard J; Thinard R; Cherifi Y; Menoret S; Fontanière S; de Crozé N; Fraichard A; Sohm F; Anegon I; Concordet JP; Giovannangeli C
    Cell Rep; 2016 Mar; 14(9):2263-2272. PubMed ID: 26923600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hPSC gene editing for cardiac disease therapy.
    Saleem A; Abbas MK; Wang Y; Lan F
    Pflugers Arch; 2022 Nov; 474(11):1123-1132. PubMed ID: 36163402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
    Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
    Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.